/AWKN.NE

AWKN.NE Stock - Awakn Life Sciences Corp.

Q: What is the analyst price target for AWKN.NE?

Analyst price target information is not currently available for AWKN.NE.

Q: What is AWKN.NE's market cap?

Market capitalization information is not currently available for AWKN.NE.

Healthcare|Biotechnology|NEO

$0.10-25.93%

$0.04 (-25.93%) • Dec 6

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.11

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for AWKN.NE

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.85

52W High$0.17

52W Low$0.10

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021
Revenue	$1.50M	$236,037
Gross Profit	$-1,554,685	$-276,833
Gross Margin	-104.0%	-117.3%
Operating Income	$-9,194,090	$-9,783,622
Net Income	$-9,142,555	$-15,945,845
Net Margin	-611.4%	-6755.7%
EPS	$-0.36	$-0.73

Company Overview

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.

Visit Website

Earnings History & Surprises

AWKN.NE

Beat Rate

50%

Last 6 quarters

Avg Surprise

+11.6%

EPS vs Estimate

Beats / Misses

3/2

1 met exactly

Latest EPS

$-0.02

Q4 2023

EPS Surprise History

Q1 22

No data

Q2 22

+35.3%

$-0.11vs$-0.17

Q3 22

0.0%

$-0.09vs$-0.09

Q4 22

+50.0%

$-0.05vs$-0.10

Q1 23

No data

Q2 23

-20.0%

$-0.06vs$-0.05

Q3 23

-25.0%

$-0.05vs$-0.04

Q4 23

+29.3%

$-0.02vs$-0.03

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 14, 2023	$-0.03	$-0.02	+29.3%	✓ BEAT
Q3 2023	Sep 14, 2023	$-0.04	$-0.05	-25.0%	✗ MISS
Q2 2023	Jun 14, 2023	$-0.05	$-0.06	-20.0%	✗ MISS
Q1 2023	Jan 31, 2023	—	$-0.09	—	—
Q4 2022	Dec 15, 2022	$-0.10	$-0.05	+50.0%	✓ BEAT
Q3 2022	Sep 14, 2022	$-0.09	$-0.09	0.0%	= MET
Q2 2022	Jun 14, 2022	$-0.17	$-0.11	+35.3%	✓ BEAT
Q1 2022	Jan 31, 2022	—	$-0.17	—	—
Q4 2021	Dec 15, 2021	—	$-0.12	—	—
Q3 2021	Sep 14, 2021	—	$-0.37	—	—
Q2 2021	Apr 30, 2021	—	$-0.05	—	—

Frequently Asked Questions about AWKN.NE

What is AWKN.NE's current stock price?

Awakn Life Sciences Corp. (AWKN.NE) is currently trading at $0.10 per share. The stock has moved -25.93% today.

What is the analyst price target for AWKN.NE?

No analyst price targets are currently available for this stock.

What sector is Awakn Life Sciences Corp. in?

Awakn Life Sciences Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NEO exchange.

What is AWKN.NE's market cap?

Awakn Life Sciences Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does AWKN.NE pay dividends?

No, Awakn Life Sciences Corp. does not currently pay a dividend to shareholders.